ACACIA RESEARCH CENTER
Breaking barriers and discovering the most effective treatments for mental illness.
Acacia Research Center results are inspiring, life-changing, and a reminder that the pursuit of better mental health care should never be stagnant. There is so much to discover; we have a lot of work to do.
What we do
In-House Research
The Acacia Research Center (ARC) is dedicated to advancing neuroscience and revolutionizing neuromodulation treatment. Our in-house research team analyzes real-world treatment outcomes data to fully understand the efficacy of novel TMS approaches. These findings help inform and guide decision-making, enabling continuous optimization of personalized treatment protocols
Sponsors & Partnerships
At ARC, we collaborate with industry and academic partners to conduct pioneering clinical trials. We provide comprehensive services, including project management and FDA-level inspection support. Partnering with us saves sponsors valuable time due to our well-equipped infrastructure and certified staff ensuring strict regulatory compliance and participant safety.
Publishing Research
Acacia team members have a strong track record of publishing in the fields of neuropsychiatry, brain imaging, and neuromodulation. We've disseminated our research through peer-reviewed articles, abstracts, and presentations at international conferences, contributing to the advancement of healthcare knowledge and the improvement of patient care.
CURRENT RESEARCH STUDIES
Recruiting Participants with Major Depressive Disorder for a Paid Observational Biomarker Study
Are you starting TMS or Spravato treatment at Acacia Clinics? You may be eligible to participate in our research study.
Kernel is conducting a study at Acacia Clinics with a revolutionary technology that can non-invasively measure brain activity in real time. Patients who are starting TMS or SPRAVATO® (esketamine) for depression at Acacia may be eligible for this study and receive a summary of their brain results.
PARTICIPANT REQUIREMENTS
This study may be an option for adults who are:
18-65 years of age
Fluent in English
Primary diagnosis of Major Depressive Disorder
Are scheduled to receive TMS or Spravato treatment
CURRENT RESEARCH STUDIES
Are you starting TMS or Spravato treatment at Acacia Clinics? You may be eligible to participate in our research study.
We are conducting a research study to develop better ways to personalize mental health treatments. Our study uses voice analysis technology to understand how people might respond to Transcranial Magnetic Stimulation (TMS) or Spravato (esketamine) treatments.
Improving Mental Health Treatment Through Voice Analysis
PARTICIPANT REQUIREMENTS
You may be eligible if you:
Are between 18-68 years old
Have been diagnosed with at least one of the following conditions:
Major Depressive Disorder (MDD)
Post-Traumatic Stress Disorder (PTSD)
Obsessive-Compulsive Disorder (OCD)
Generalized Anxiety Disorder (GAD)
Bipolar Disorder
Are scheduled to receive TMS or Spravato treatment
Are fluent in English
Have access to a device with internet connection and a microphone
RESEARCH TEAM
Acacia’s research leadership team is at the forefront of TMS and neuroscientific research, leading and co-authoring dozens of renowned research publications.
Danielle DeSouza, PhD
VP of Research
Erica Nakano
Clinical Research Associate (CRA)
Laura Schulze, PhD
Scientist
Vivian Hoang
Clinical Research Coordinator (CRC)
